Antiplatelet therapy before, during, and after extremity revascularization

被引：9

作者：

Yang, Jane K. ^{[1
]}

Jimenez, Juan Carlos ^{[1
]}

Jabori, Sinan ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Div Vasc Surg, Los Angeles, CA 90095 USA

来源：

JOURNAL OF VASCULAR SURGERY | 2014年 / 60卷 / 04期

关键词：

AMERICAN-COLLEGE; CLOPIDOGREL; METAANALYSIS; ANGIOPLASTY; PREVENTION; THROMBOSIS; ASPIRIN; DISEASE; GRAFTS;

D O I：

10.1016/j.jvs.2014.07.006

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Peripheral arterial disease (PAD) is well recognized as a marker for systemic atherosclerosis. Platelets play an essential role in all stages of the disease, contributing to both thrombosis and the development of atherosclerosis. Medication regimens to optimize outcomes in both patients who are to undergo revascularization and those who will be managed without interventional therapy must address antiplatelet therapy. Given the common cardiovascular and cerebrovascular comorbidities in patients with PAD, antiplatelet therapy has the potential to decrease thromboembolic events in addition to improving patency after interventions. This clinical update reviews the current literature and recommendations for antiplatelet therapy in patients with PAD.

引用

页码：1085 / 1091

页数：7

共 33 条

[11] Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation [J].

Geisler, Tobias ;

Anders, Nicole ;

Paterok, Maria ;

Langer, Harald ;

Stellos, Konstantinos ;

Lindemann, Stephan ;

Herdeg, Christian ;

May, Andreas E. ;

Gawaz, Meinrad .

DIABETES CARE, 2007, 30 (02) :372-374

[12] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].

Gent, M ;

Beaumont, D ;

Blanchard, J ;

Bousser, MG ;

Coffman, J ;

Easton, JD ;

Hampton, JR ;

Harker, LA ;

Janzon, L ;

Kusmierek, JJE ;

Panak, E ;

Roberts, RS ;

Shannon, JS ;

Sicurella, J ;

Tognoni, G ;

Topol, EJ ;

Verstraete, M ;

Warlow, C .

LANCET, 1996, 348 (9038) :1329-1339

[13] Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery [J].

Geraghty, Alistair J. ;

Welch, Karen .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (06)

[14] FEMORO-POPLITEAL BYPASS GRAFTS - AN ISOTOPE TECHNIQUE ALLOWING INVIVO COMPARISON OF THROMBOGENICITY [J].

GOLDMAN, M ;

NORCOTT, HC ;

HAWKER, RJ ;

HAIL, C ;

DROLC, Z ;

MCCOLLUM, CN .

BRITISH JOURNAL OF SURGERY, 1982, 69 (07) :380-382

[15] ASPIRIN AND DIPYRIDAMOLE REDUCE PLATELET DEPOSITION ON PROSTHETIC FEMORO-POPLITEAL GRAFTS IN MAN [J].

GOLDMAN, MD ;

SIMPSON, D ;

HAWKER, RJ ;

NORCOTT, HC ;

MCCOLLUM, CN .

ANNALS OF SURGERY, 1983, 198 (06) :713-716

[16] Cilostazol Reduces Angiographic Restenosis After Endovascular Therapy for Femoropopliteal Lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol Study [J].

Iida, Osamu ;

Yokoi, Hiroyoshi ;

Soga, Yoshimitsu ;

Inoue, Naoto ;

Suzuki, Kenji ;

Yokoi, Yoshiaki ;

Kawasaki, Daizo ;

Zen, Kan ;

Urasawa, Kazushi ;

Shintani, Yoshiaki ;

Miyamoto, Akira ;

Hirano, Keisuke ;

Miyashita, Yusuke ;

Tsuchiya, Taketsugu ;

Shinozaki, Norihiko ;

Nakamura, Masato ;

Isshiki, Takaaki ;

Hamasaki, Toshimitsu ;

Nanto, Shinsuke .

CIRCULATION, 2013, 127 (23) :2307-2315

[17]

Johnston L, 2014, 42 ANN S SOC CLIN VA

[18]

Kilic A, 2014, 42 ANN S SOC CLIN VA

[19] DUAL ANTIPLATELET THERAPY RESPONSIVENESS IN PATIENTS UNDERGOING PERCUTANEOUS REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIVE DISEASE [J].

Kliger, Chad ;

Babaev, Anvar ;

Shah, Binita ;

Feit, Frederick ;

Slater, James ;

Attubato, Michael .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) :E2049-E2049

[20]

Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475

← 1 2 3 4 →